We are live on
!
Find out more
PP
PDT Partners Portfolio holdings
AUM
$1.69B
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
-2.03%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.68B
AUM Growth
-$7.95M
(-0.47%)
Cap. Flow
+$55.2M
Cap. Flow
% of AUM
3.28%
Top 10 Holdings %
Top 10 Hldgs %
17.16%
Holding
515
New
107
Increased
139
Reduced
156
Closed
69
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$46.2M |
| 2 |
Ferrari
RACE
|
+$26.2M |
| 3 |
HF Sinclair
DINO
|
+$10.4M |
| 4 |
Pfizer
PFE
|
+$10.1M |
| 5 |
TechnipFMC
FTI
|
+$9.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$51.3M |
| 2 |
Mettler-Toledo International
MTD
|
+$37.2M |
| 3 |
Autodesk
ADSK
|
+$26M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$25.6M |
| 5 |
Trimble
TRMB
|
+$12.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.95% |
| 2 | Technology | 20.52% |
| 3 | Consumer Discretionary | 16.46% |
| 4 | Industrials | 8.03% |
| 5 | Financials | 6.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Materion
MTRN
$4.84B
| $1.04M | 0.06% |
+16,900
| New | +$1.05M |
|
|
NVMI
277
Nova
NVMI
$13.3B
| $1.03M | 0.06% |
32,300
-400
| -1% | -$11.4K |
|
|
CRCM
278
DELISTED
CARE.COM, INC.
CRCM
| $1.02M | 0.06% |
97,346
-132
| -0.1% | -$1.36K |
|
279
ArcelorMittal
MT
$49.7B
| $1.01M | 0.06% |
+71,006
| New | +$1.09M |
|
280
Sonic Automotive
SAH
$3.21B
| $999K | 0.06% |
+31,800
| New | +$860K |
|
|
CNSL
281
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $994K | 0.06% |
208,800
-36,104
| -15% | -$170K |
|
282
Chemours
CC
$2.53B
| $991K | 0.06% |
+66,330
| New | +$1.08M |
|
|
CPRX
283
DELISTED
Catalyst Pharmaceutical
CPRX
| $981K | 0.06% |
+184,805
| New | +$985K |
|
284
Helix Energy Solutions
HLX
$1.43B
| $975K | 0.06% |
+120,968
| New | +$976K |
|
|
ITCI
285
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $969K | 0.06% |
129,741
+84,537
| +187% | +$811K |
|
|
VSLR
286
DELISTED
VIVINT SOLAR, INC.
VSLR
| $962K | 0.06% |
147,100
+57,097
| +63% | +$452K |
|
287
Rithm Capital
RITM
$5.17B
| $961K | 0.06% |
+61,300
| New | +$918K |
|
288
IMAX
IMAX
$2.44B
| $957K | 0.06% |
43,607
-14,381
| -25% | -$305K |
|
|
SPPI
289
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $949K | 0.06% |
+114,359
| New | +$925K |
|
290
Twist Bioscience
TWST
$5.42B
| $939K | 0.06% |
39,316
+21,516
| +121% | +$625K |
|
291
Wave Life Sciences
WVE
$1.14B
| $899K | 0.05% |
43,800
-7,700
| -15% | -$177K |
|
292
SiriusPoint
SPNT
$3.01B
| $887K | 0.05% |
88,800
| – | – |
|
293
Lakeland Financial Corp
LKFN
$1.54B
| $884K | 0.05% |
20,089
-987
| -5% | -$43.6K |
|
294
Impinj
PI
$3.88B
| $873K | 0.05% |
28,323
+6,809
| +32% | +$238K |
|
295
CareDx
CDNA
$1.9B
| $800K | 0.05% |
35,404
-45,396
| -56% | -$1.26M |
|
296
Cannae Holdings
CNNE
$650M
| $795K | 0.05% |
28,937
+37
| +0.1% | +$1.05K |
|
297
Intellia Therapeutics
NTLA
$1.5B
| $777K | 0.05% |
58,200
-88
| -0.2% | -$1.4K |
|
298
OFG Bancorp
OFG
$2.23B
| $775K | 0.05% |
35,410
-2
| -0% | -$44 |
|
299
Tactile Systems Technology
TCMD
$627M
| $766K | 0.05% |
18,100
-12,600
| -41% | -$651K |
|
|
MODN
300
DELISTED
MODEL N, INC.
MODN
| $763K | 0.05% |
27,500
+7,043
| +34% | +$175K |
|
Similar funds
ISS
GAM
BCM
FACM
TCBWMS
WAS
SGI
AAM
PDT Partners's Q3 2019 Portfolio in Review
As of Q3 2019, PDT Partners held 515 positions worth $1.68B, down 0.47% from $1.69B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
PDT Partners deployed $55.2M of net new capital in Q3 2019, opening 107 new positions and adding to 139 existing holdings. Its largest new stake was Linde: 238,663 shares worth $46.2M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was AbbVie, an estimated $51.3M trimmed.
- PDT Partners's largest Q3 2019 buy was Linde: 238,663 shares worth $46.2M.
- PDT Partners added most to Ferrari in Q3 2019, an estimated $26.2M increase.
- PDT Partners's biggest Q3 2019 reduction was AbbVie, cutting an estimated $51.3M.
- PDT Partners fully exited Mettler-Toledo International in Q3 2019, selling an estimated $37.2M.
- PDT Partners's ten largest holdings make up 17% of its $1.68B portfolio in Q3 2019.
- PDT Partners opened 107 new positions and closed 69 in Q3 2019.
- PDT Partners's portfolio value fell 0.47% quarter-over-quarter to $1.68B.
Based on PDT Partners's 13F filing for Q3 2019, filed 14 Nov 2019.